Form 4: Senseonics Holdings Executive Francine Kaufman Acquires 1,024,270 Shares of Common Stock

Francine Kaufman, Chief Medical Officer of Senseonics Holdings, Inc., acquired 1,024,270 shares of common stock through a restricted stock unit grant.

Summary

• On May 23, 2024, Francine Kaufman, the Chief Medical Officer of Senseonics Holdings, Inc., acquired 1,024,270 shares of common stock.
• This acquisition was a result of a restricted stock unit (RSU) grant.
• The RSUs vest in eight equal installments, starting on June 15, 2024, and continuing in six-month increments until November 15, 2024, contingent upon continuous service with the Issuer.
• Each RSU represents a contingent right to receive one share of Senseonics Holdings' common stock.
• Following this transaction, Kaufman directly owns 2,429,148 shares of Senseonics Holdings, Inc.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The acquisition of shares by a key executive is generally viewed favorably, suggesting confidence in the company's prospects. However, it's a routine transaction (RSU grant) and doesn't necessarily indicate a major shift in the company's outlook.

Positives

• The acquisition of shares by a key executive may signal confidence in the company's future prospects.

Future Outlook

The RSUs vest over time, contingent on the Reporting Person's continuous service with the Issuer.

Industry Context

Executive stock ownership is a common practice in publicly traded companies and is often seen as a way to align the interests of management with those of shareholders.

Stakeholder Impact

• Shareholders may view the executive's increased stake in the company positively.

Key Dates